EL PASO, Texas--(BUSINESS WIRE)--Premier Biomedical, Inc. (OTCBB: “BIEI”) a biopharmaceutical company focused on developing and commercializing innovative treatment therapies for cancer, traumatic brain injury, Alzheimer’s disease, and other afflictions announced today that they have initiated discussions with William Beaumont Army Medical Center (WBAMC) at Ft. Bliss, TX toward initiating staged clinical trials to treat soldiers suffering from head trauma leading to clinical depression (PTSD) and possible resultant suicide/homicide ideation. This follows and builds on the successful laboratory work completed by the company and its affiliates to date to measure and eliminate specific molecular compounds from cerebral-spinal fluid (CSF) believed to be responsible for these afflictions.
Help employers find you! Check out all the jobs and post your resume.
